Entrada Therapeutics (TRDA) Asset Utilization Ratio (2023 - 2025)
Historic Asset Utilization Ratio for Entrada Therapeutics (TRDA) over the last 3 years, with Q3 2025 value amounting to 0.14.
- Entrada Therapeutics' Asset Utilization Ratio fell 6229.9% to 0.14 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.14, marking a year-over-year decrease of 6229.9%. This contributed to the annual value of 0.42 for FY2024, which is 1836.89% up from last year.
- According to the latest figures from Q3 2025, Entrada Therapeutics' Asset Utilization Ratio is 0.14, which was down 6229.9% from 0.17 recorded in Q2 2025.
- Entrada Therapeutics' 5-year Asset Utilization Ratio high stood at 0.44 for Q2 2024, and its period low was 0.07 during Q1 2023.
- Moreover, its 3-year median value for Asset Utilization Ratio was 0.27 (2023), whereas its average is 0.25.
- Per our database at Business Quant, Entrada Therapeutics' Asset Utilization Ratio skyrocketed by 38905.37% in 2024 and then plummeted by 6229.9% in 2025.
- Quarter analysis of 3 years shows Entrada Therapeutics' Asset Utilization Ratio stood at 0.27 in 2023, then surged by 44.23% to 0.39 in 2024, then tumbled by 63.39% to 0.14 in 2025.
- Its Asset Utilization Ratio stands at 0.14 for Q3 2025, versus 0.17 for Q2 2025 and 0.34 for Q1 2025.